Navigation Links
Frost & Sullivan: U.S. Nuclear Medicine and PET Imaging Systems Market Witnessed a Rebound in 2010, With PET Blazing the Trail
Date:3/29/2012

MOUNTAIN VIEW, Calif., March 29, 2012 /PRNewswire/ -- After witnessing a downtrend for several years, revenues in the U.S. nuclear medicine and positron emission tomography (PET) imaging systems market finally pivoted in 2010. New radiotracers and technologies are expanding the clinical scope and customer base of nuclear medicine and PET imaging. As a result, declines in retrenching areas of the market are poised to be offset by strong growth in emerging end-user market segments.

Nuclear medicine and PET are molecular imaging modalities, providing data pertaining to molecular alterations, which are the origin of disease. In contrast, classical imaging modalities, such as X-ray, reveal only the changes in anatomy, which are essentially the end effects of disease and its associated molecular alterations.

New analysis from Frost & Sullivan's (http://www.medicalimaging.frost.com) U.S. Nuclear Medicine and PET Imaging Systems Market research finds that the market earned revenues of $552.4 million in 2010 and estimates this figure to reach $841.8 million in 2017.

If you are interested in more information on this research, please send an email to Britni Myers, Corporate Communications, at britni.myers@frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

"The unique ability of nuclear medicine and PET to enable characterization of biological processes at the cellular and molecular levels is bringing increasing attention to these imaging modalities as medicine evolves toward more personalized forms of treatment," said Frost & Sullivan Industry Analyst Roberto G. Aranibar. "This powerful capability of nuclear medicine and PET will become increasingly relevant as personalized healthcare becomes mainstream practice in modern medicine."

Recognizing this advantage, industry participants are gravitating toward this area of imaging. As a result, nuclear medicine and PET imaging systems market revenues experienced a growth upsurge in 2010, and they are expected to continue growing for the next several years.

Molecular imaging has been a key enabling factor for treatment that is selected according to a patient's unique disease state. For example, in cancer treatments, numerous chemotherapy options are available, and a patient's response to a particular treatment can vary considerably based on the specific molecular characteristics of the cancer. With molecular imaging, however, clinicians can determine which characteristics are present in a cancer and use this information to make the most appropriate treatment decision on a patient-by-patient basis.

Ongoing challenges surrounding the state of the economy as well as changes in healthcare policy and reimbursement are forcing more private practice physicians and independent imaging centers to opt for affiliation with larger provider organizations. This shift in the healthcare provider landscape has led to rapidly diminishing revenues within the private practice cardiology market, which formerly accounted for a significant proportion of revenues in the more mature and established nuclear medicine segment of the market.

Naturally, the evolving healthcare provider landscape has led to changes in the types of imaging systems that are being demanded in the marketplace. For example, the need for dedicated cardiac scanners appears to be diminishing, as more cardiologists become affiliated with larger institutions that often benefit more from general-purpose scanners with a broader scope of clinical application.

"Nuclear medicine imaging equipment manufacturers that previously offered only dedicated cardiac scanners have reacted to changes in the healthcare provider landscape by further diversifying their product portfolios in order to include clinically versatile, general-purpose gamma camera systems," said Aranibar. "A number of manufacturers have also chosen to focus on other niche, yet emerging, applications of nuclear medicine and PET that involve molecular breast imaging and brain imaging."

U.S. Nuclear Medicine and PET Imaging Systems Market is part of the Advanced Medical Technologies Growth Partnership Service program, which also includes research in the following markets: North American Market for Computer-aided Detection and Diagnosis, U.S. Preclinical Small Animal Imaging Markets, and North American Advanced 3-D/4-D Visualization and Clinical Applications for Medical Imaging Markets. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

U.S. Nuclear Medicine and PET Imaging Systems Market

N8E8

Contact:
Britni Myers
Corporate Communications – North America
P: 210.477.8481
F: 210.348.1003
E: britni.myers@frost.com

http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market
2. Frost & Sullivans Advanced Medical Technologies Research Tracks Opportunities in Markets Influenced by Dynamic Care Pathways
3. Frost & Sullivans Global Healthcare Approach Evolves to Contend with Todays Challenges
4. Frost & Sullivan New Product Innovation Award Presented to Brainsway for Its Deep Transcranial Magnetic Stimulation (dTMS) Device
5. Frost & Sullivan Lauds Siemens Healthcares Unique, Multipurpose Gamma Camera that Sets it Apart from the Competition in the Nuclear Cardiology Market
6. A Secret to Ward Off Jack Frosts Drying Effect on Your Skin: The AmLactin® Family of Moisturizers
7. Frost and Sullivan Recognizes AT&Ts Innovative mHealth Strategy
8. Frost & Sullivan Honors Acuo Technologies with Product Leadership Award in Medical Imaging Informatics
9. KJAYA Medical Honored with 2011 Frost & Sullivan Award for Technology Innovation in Web-based Medical Imaging Data Management
10. Frost & Sullivan Speaks Candidly with U.S. Pharmacists
11. Frost & Sullivan Honors ZONARE for Ultrasound Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):